Tagrisso (osimertinib) - AstraZeneca
Yervoy (ipilimumab) - BMS
everolimus - Generic mfg.
carboplatin - Generic mfg.
irinotecan - Generic mfg.
bumetanide - Generic mfg.
temozolomide - Generic mfg.
Implantable Microdevice In Primary Brain Tumors (clinicaltrials.gov) - Oct 17, 2026 - P1 | N=30 | Recruiting | Sponsor: Oliver Jonas | N=12 ➔ 30 | Trial primary completion date: Sep 2027 ➔ Jan 2028 
Enrollment change • Trial primary completion date • Anaplastic Astrocytoma • Anaplastic Oligoastrocytoma • Astrocytoma • Brain Cancer • Glioblastoma • Glioma • Oligodendroglioma • Oncology • Solid Tumor
http://clinicaltrials.gov/ct2/show/NCT04135807
 
Oct 17, 2026
 
Prev Next